INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Lobbying registrant
TG

THE MCMANUS GROUP

Open in network
Disclosed transactions0
Buys / sells0 / 0
Max Insider Score—
Connections8with evidence

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

  • Lobbied forevidence
    GILEAD SCIENCES, INC.LDA Q2 2026 second quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
  • Lobbied forevidence
    GRAIL, Inc.LDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    Owlet, Inc.LDA Q1 2026 first quarter · Health issues, Budget/appropriations · Aug 26, 2026
  • Lobbied forevidence
    BRISTOL MYERS SQUIBB COLDA Q2 2026 second quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
  • Lobbied forevidence
    AMGEN INCLDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    Fulcrum Therapeutics, Inc.LDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    Sight Sciences, Inc.LDA 1T 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    ARDELYX, INC.LDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026